Nalls Sherbakoff Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$147K Buy
711
+308
+76% +$60.9K 0.11% 121
2025
Q3
$74.7K Hold
403
0.05% 169
2025
Q2
$61.6K Buy
403
+50
+14% +$7.69K 0.04% 181
2025
Q1
$58.6K Buy
+353
New +$55.2K 0.05% 169
2023
Q4
$60K Buy
383
+1
+0.3% +$153 0.05% 153
2023
Q3
$59.6K Sell
382
-105
-22% -$17.3K 0.06% 144
2023
Q2
$75.5K Sell
487
-118
-20% -$19K 0.07% 132
2023
Q1
$92.8K Buy
+605
New +$97.7K 0.09% 118
2018
Q4
$400K Buy
+3,102
New +$433K 0.64% 33

Other funds holding JNJ

Nalls Sherbakoff Group's JNJ Position: Q4 2025 in Review

Nalls Sherbakoff Group increased its Johnson & Johnson (JNJ) stake by 76% in Q4 2025, buying an estimated $60.9K and bringing the position to 711 shares worth $147K. The position accounts for 0.11% of the portfolio, ranked #121.

Nalls Sherbakoff Group first reported a position in JNJ in Q4 2018 and has held it in 9 quarters since. The position peaked at $400K in Q4 2018. 4,521 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

  • Nalls Sherbakoff Group held 711 shares of Johnson & Johnson worth $147K as of Q4 2025.
  • Nalls Sherbakoff Group bought 308 Johnson & Johnson shares in Q4 2025, an estimated $60.9K.
  • Johnson & Johnson made up 0.11% of Nalls Sherbakoff Group's portfolio in Q4 2025, its #121 holding.
  • Nalls Sherbakoff Group first reported a position in Johnson & Johnson in Q4 2018 and has held it in 9 quarters since.
  • Nalls Sherbakoff Group's Johnson & Johnson position peaked at $400K in Q4 2018.
  • 4,521 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on Nalls Sherbakoff Group's 13F filing for Q4 2025, filed 12 Mar 2026.